作者单位:
Department of Medicine (Section of Medical Oncology), Yale University School of Medicine, New Haven, Connecticut.;Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut.
[1]
Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut.;Clinica Universidad de Navarra and CIMA, Pamplona, Spain.;CIBERONC, Madrid, Spain.;Insitituto de Investigacion Sanitaria de Navarra (IDISNA), Pamplona, Spain.
[2]
Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut.
[3]
Department of Medicine (Section of Medical Oncology), Yale University School of Medicine, New Haven, Connecticut.;Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut.;Department of Pathology, Yale University School of Medicine, New Haven, Connecticut.
[4]
Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut.
[5]
Clinica Universidad de Navarra and CIMA, Pamplona, Spain.;CIBERONC, Madrid, Spain.;Insitituto de Investigacion Sanitaria de Navarra (IDISNA), Pamplona, Spain.
[6]
Department of Medicine (Section of Medical Oncology), Yale University School of Medicine, New Haven, Connecticut. roy.herbst@yale.edu.;Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut.
[7]
DOI
10.1158/1078-0432.CCR-18-1538
PMID
30824587
发布时间
2024-07-19